C9 anticorps (Internal Region)
-
- Antigène Voir toutes C9 Anticorps
- C9 (Complement Component C9 (C9))
-
Épitope
- Internal Region
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp C9 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Specificité
- Human C9
- Homologie
- Percent identity by BLAST analysis:
- Purification
- Immunoaffinity purified
- Immunogène
-
Recombinant fragment corresponding to a region within amino acids 153 and 429 of C9 (SwissProt P02748). Percent identity by BLAST analysis:
Type of Immunogen: Recombinant protein - Isotype
- IgG
- Top Product
- Discover our top product C9 Anticorps primaire
-
anti-Complement Component C9 (C9) (AA 191-220), (Center) antibody
C9 Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB33918 unconjugated
anti-Complement Component C9 (C9) (AA 22-265) antibodyC9 Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 136-512) antibodyC9 Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 139-519) antibodyC9 Reactivité: Lapin WB, IHC, IP, ICC Hôte: Cobaye Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 191-220) antibodyC9 Reactivité: Humain WB, IHC, ELISA Hôte: Lapin Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 336-554) antibodyC9 Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 205-216) antibodyVerified C9 Reactivité: Humain WB, ELISA Hôte: Chèvre Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 184-411) antibodyC9 Reactivité: Humain WB, ICC, IHC (p), IF Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
-
Approved: IHC, IHC-P (1:100 - 1:1000), WB (1:500 - 1:3000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000, IHC-Paraffin: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10 mM Citrate buffer ( pH 6.0) or Tris-EDTA buffer ( pH 8.0)]. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
- Agent conservateur
- Thimerosal (Merthiolate)
- Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
- Antigène
- C9 (Complement Component C9 (C9))
- Autre désignation
- Complement C9 (C9 Produits)
- Synonymes
- anticorps LOC100037951, anticorps LOC100136130, anticorps c9, anticorps wu:fb60b05, anticorps wu:fd50e04, anticorps zgc:112272, anticorps complement C9, anticorps complement component 9, anticorps complement component 9 L homeolog, anticorps C9, anticorps c9, anticorps c9.L
- Sujet
-
Name/Gene ID: C9
Subfamily: Complement Component
Synonyms: C9, Complement C9, Complement component 9, Complement component C9 - ID gène
- 735
- UniProt
- P02748
- Pathways
- Système du Complément
-
